Evidence map›Paper›PMID 37570620›Full record

ArticleMolecules (Basel, Switzerland)2023

Simultaneous Enhancement of Flame Resistance and Antimicrobial Activity in Epoxy Nanocomposites Containing Phosphorus and Silver-Based Additives.

Tăchiță Vlad-Bubulac, Corneliu Hamciuc, Diana Serbezeanu, Ana-Maria Macsim, Gabriela Lisa, Ion Anghel, Dana-Maria Preda, Yuri Kalvachev, Cristina Mihaela Rîmbu

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Tăchiță Vlad-BubulacDepartment of Polycondensation and Thermally Stable Polymers, "Petru Poni" Institute of Macromolecular Chemistry, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.ORCID 0000-0002-9017-9926
Corneliu HamciucDepartment of Polycondensation and Thermally Stable Polymers, "Petru Poni" Institute of Macromolecular Chemistry, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.ORCID 0000-0001-9454-4399
Diana SerbezeanuDepartment of Polycondensation and Thermally Stable Polymers, "Petru Poni" Institute of Macromolecular Chemistry, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.ORCID 0000-0001-8544-5671
Ana-Maria MacsimDepartment of Polycondensation and Thermally Stable Polymers, "Petru Poni" Institute of Macromolecular Chemistry, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.ORCID 0000-0002-5107-6369
Gabriela LisaDepartment of Chemical Engineering, Faculty of Chemical Engineering and Environmental Protection, "Gheorghe Asachi" Technical University of Iasi, 73 Bd. Mangeron, 700050 Iasi, Romania.ORCID 0000-0002-4541-7446
Ion AnghelFire Officers Faculty, Police Academy "Alexandru Ioan Cuza", 3 Morarilor St., Sector 2, 022451 Bucharest, Romania.ORCID 0000-0002-5397-7638
Dana-Maria PredaFire Officers Faculty, Police Academy "Alexandru Ioan Cuza", 3 Morarilor St., Sector 2, 022451 Bucharest, Romania.ORCID 0000-0002-2497-8148
Yuri KalvachevInstitute of Catalysis, Bulgarian Academy of Sciences, Acad. G. Bonchev St., bl.11, 1113 Sofia, Bulgaria.ORCID 0000-0002-4084-8458
Cristina Mihaela RîmbuDepartment of Public Health, "Ion Ionescu de la Brad" Iasi University of Life Sciences, 8 Sadoveanu Alley, 707027 Iasi, Romania.ORCID 0000-0003-0982-0040
Academia de Politie Alexandru Ioan Cuza · ROBulgarian Academy of Sciences · BGGheorghe Asachi Technical University of Iași · RO"Ion Ionescu de la Brad" Iasi University of Life Sciences · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The design and manufacture of innovative multifunctional materials possessing superior characteristics, quality and standards, rigorously required for future development of existing or emerging advanced technologies, is of great importance. These materials should have a very low degree of influence (or none) on the environmental and human health. Adjusting the properties of epoxy resins with organophosphorus compounds and silver-containing additives is key to the simultaneous improvement of the flame-resistant and antimicrobial properties of advanced epoxy-based materials. These environmentally friendly epoxy resin nanocomposites were manufactured using two additives, a reactive phosphorus-containing bisphenol derived from vanillin, namely, (4-(((4-hidroxyphenyl)amino)(6-oxido-6H-dibenzo[c,e][1,2]oxaphosphinin-6-yl)methyl)-2-methoxyphenyl) phenylphosphonate (BPH), designed as both cross-linking agent and a flame-retardant additive for epoxy resin; and additional silver-loaded zeolite L nanoparticles (Ze-Ag NPs) used as a doping additive to impart antimicrobial activity. The effect of BPH and Ze-Ag NPs content on the structural, morphological, thermal, flame resistance and antimicrobial characteristics of thermosetting epoxy nanocomposites was investigated. The structure and morphology of epoxy nanocomposites were investigated via FTIR spectroscopy and scanning electron microscopy (SEM). In general, the nanocomposites had a glassy and homogeneous morphology. The samples showed a single glass transition temperature in the range of 166-194 °C and an initiation decomposition temperature in the range of 332-399 °C. The introduction of Ze-Ag NPs in a concentration of 7-15 wt% provided antimicrobial activity to epoxy thermosets.

Indexed as

antimicrobial activityepoxy nanocompositesflame resistantphosphorus-containing bisphenolthermal stabilityzeolite-silver nanoparticles

Identifiers

PMID37570620
PMCPMC10419371
OpenAlexW4385278790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.